Businessweek

YungShin Global Holding Corporation, together with its subsidiaries, engages in the production and sale of pharmaceutical products. It offers a range of general medicine in various treatment categories; develops, produces, and sells API and special chemical products; retails OTC products; and produces Paclitaxel and its derivatives, and medical/health-promoting herbal products, including medical herbal materials, medical intermediates, anti-cancer APIs, and health foods. The company also develops and produces health and beauty products, such as Yu-kang grade-seed extract chewables, bilberry chewables, Meiganic plum extract chewables, cranberry capsules for women, green tea capsules for weight loss, ginkgo tablets for mental functioning, oyster-extract tablets and kudzu vine root tablets for liver protection, oat capsules as a sleep aid, and soybean tablets for women. In addition, it offers Western medicines and agricultural products to hospitals, clinics, pharmacies, and distributors of pesticides; and produces tablets, capsules, suppositories, and ointments, as well as provides OTC, animal, and aqua cultural medicine. Further, the company provides grants for medical research; operates a nursing home for senior care; and promotes healthy lifestyles by holding volleyball championships. YungShin Global Holding Corporation sells its products in the Asia Pacific, the Middle East, southeast Asia, North America, and Latin America. The company was founded in 1952 and is based in Taichung, Taiwan.